Your browser doesn't support javascript.
loading
Physical therapy pathway and protocol for patients undergoing hematopoietic stem cell transplantation: Recommendations from The Eastern Mediterranean Blood and Marrow Transplantation (EMBMT) Group.
Mohammed, Jaleel; Aljurf, Mahmoud; Althumayri, Abdulaziz; Almansour, Muntaha; Alghamdi, Ahmed; Hamidieh, Amir Ali; ElHaddad, Alaa; Othman, Tarek Ben; Bazarbachi, Ali; Almohareb, Fahad; Alzahrani, Mohsen; Alkindi, Salam S; Alsharif, Fahad; Da'na, Waleed; Alhashmi, Hani; Bekadja, Mohamed A; Al-Shammari, Salem H; El Quessar, Asma; Satti, Tariq M; Aljohani, Naif; Rasheed, Walid; Ghavamzadeh, Ardeshir; Chaudhri, Naeem; Hashmi, Shahrukh K.
Afiliação
  • Mohammed J; Department of Physical Therapy and Rehabilitation, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia; Rehabilitation department, Physical Therapy Association for Graft Versus Host Disease, Swindon, UK. Electronic address: qualityfrlife@gmail.com.
  • Aljurf M; Department of Physical Therapy and Rehabilitation, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia; Rehabilitation department, Physical Therapy Association for Graft Versus Host Disease, Swindon, UK.
  • Althumayri A; Department of Physical Therapy and Rehabilitation, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
  • Almansour M; Department of Physical Therapy and Rehabilitation, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
  • Alghamdi A; Department of Physical Therapy and Rehabilitation, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
  • Hamidieh AA; Stem Cell Transplantation, Tehran University of Medical Sciences, Shariati Hospital, Tehran, Iran.
  • ElHaddad A; Oncology, National Cancer Institute, Cairo University, Giza, Egypt.
  • Othman TB; Hematology, Centre National De Greffe De La Moelle Osseuse, Tunis, Tunisia.
  • Bazarbachi A; Hematology/Oncology, American University of Beirut Medical Center, Beirut, Lebanon.
  • Almohareb F; Department of Physical Therapy and Rehabilitation, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
  • Alzahrani M; Hepatology & Hematology, National Guard Health Affairs, Riyadh, Saudi Arabia.
  • Alkindi SS; Hematology, Sultan Qaboos University Hospital, Al-Khoud, Oman.
  • Alsharif F; Department of Physical Therapy and Rehabilitation, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
  • Da'na W; Implantalogy/Hematology, King Hussein Cancer Center, Amman, Jordan.
  • Alhashmi H; Adult Hematology and Stem Cell Transplantation, King Fahad Specialist Hospital, Dammam, Saudi Arabia.
  • Bekadja MA; Department of Hematology and Cell Therapy, University Hospital EHU 1er November, Oran, Algeria.
  • Al-Shammari SH; Stem Cell Transplant, Kuwait Cancer Control Center, Kuwait.
  • El Quessar A; Hematology and Oncology Pediatric Department, University Hospital Ibn Rochd, Casablanca, Morocco.
  • Satti TM; Bone Marrow Transplant, Armed Forces Bone Marrow Transplant Centre, Rawalpindi, Pakistan.
  • Aljohani N; Adult Bone Marrow Transplant, King Faisal Specialist Hospital and Research Centre, Jeddah, Saudi Arabia.
  • Rasheed W; Department of Physical Therapy and Rehabilitation, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
  • Ghavamzadeh A; Stem Cell Transplantation, Tehran University of Medical Sciences, Shariati Hospital, Tehran, Iran.
  • Chaudhri N; Department of Physical Therapy and Rehabilitation, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.
  • Hashmi SK; Rehabilitation department, Physical Therapy Association for Graft Versus Host Disease, Swindon, UK; Hematology/Oncology, Mayo Clinic, Rochester, MN, USA.
Hematol Oncol Stem Cell Ther ; 12(3): 127-132, 2019 Sep.
Article em En | MEDLINE | ID: mdl-30653940
ABSTRACT

BACKGROUND:

Patients undergoing hematopoietic stem cell transplantation (HSCT) are often referred for physical therapy (PT) to help improve their quality of life. However, to our knowledge there is no clear PT pathway to guide therapists and patients before, during, and after HSCT.

METHODS:

A comprehensive literature review was carried out exploring the role and benefits of PT in HSCT patients. The current evidence was comlimented with recommendations and opinions from the experts in the field, which included PT's and hematology consultants from PTAGVHD and the EMBMT group.

RESULT:

A clear pathway and protocol as a working guide for rehabilitation professionals working with the HSCT patient's was developed.

CONCLUSION:

This paper not only reviews the current evidence on safe PT practice but also puts forward a protocol and pathway for HSCT rehabilitation, highlights the importance of individualized exercise intervention for HSCT patients, and outlines safe practice guidelines for the physical therapists working in this field.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Modalidades de Fisioterapia / Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Modalidades de Fisioterapia / Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article